ComboLink Therapeutics

About

ComboLink is AI enabled biotech company developing multi pharmacology antibody based therapeutics that has huge potential to change the way we treat solid tumor and other complex diseases such as auto immune and inflammation. Our platform integrates deep biological expertise, advanced computational antibody discovery tools, and antibody engineering techniques to rapidly discover and optimize high-potential therapeutic antibodies. With help of NVIDIA inception grant we have completed building our ARRAY AI/ML antibody discovery and optimization pipeline. Given our teams deep expertise in understanding solid tumor immunology and developing T cell engager antibodies, currently initiated three new highly differentiated (Compare to competitor) multi pharmacology T cell engager programs based on available literature data. Raising pre seed funding of one million to validate the concept molecules and intiate three pipeline programs that would help us to raise seed funding from larger VCs . Team has deep knowledge in solid tumor biology, antibody engineering and using computational tool for antibody discovery